Telo Genomics Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
9
- Stock Symbol
-
TELO
- Investments
-
1
- Share Price
-
$0.07
- (As of Wednesday Closing)
Telo Genomics General Information
Description
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability. The company has a single operating segment, focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions.
Contact Information
Website
www.telodx.comCorporate Office
- MaRS Centre, South Tower
- 101 College Street, Suite 200
- Toronto, Ontario M5G 1L7
- Canada
Corporate Office
- MaRS Centre, South Tower
- 101 College Street, Suite 200
- Toronto, Ontario M5G 1L7
- Canada
Telo Genomics Timeline
Telo Genomics Stock Performance
As of 16-Apr-2025, Telo Genomics’s stock price is $0.07. Its current market cap is $6.81M with 100M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.07 | $0.06 | $0.06 - $0.17 | $6.81M | 100M | 32.8K | -$0.03 |
Telo Genomics Financials Summary
As of 31-Dec-2024, Telo Genomics has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 30-Jun-2024 | FY 2023 30-Jun-2023 | FY 2022 30-Jun-2022 |
|---|---|---|---|---|
| EV | 8,817 | 9,557 | 15,337 | 13,986 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (1,710) | (1,973) | (2,079) | (1,622) |
| Net Income | (1,730) | (2,002) | (2,104) | (1,667) |
| Total Assets | 1,639 | 705 | 2,208 | 2,199 |
| Total Debt | 0 | 25 | 31 |
Telo Genomics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Telo Genomics Comparisons
Industry
Financing
Details
Telo Genomics Competitors (4)
One of Telo Genomics’s 4 competitors is Miltenyi Biotec, a Private Debt Financed company based in Bergisch Gladbach, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Miltenyi Biotec | Private Debt Financed | Bergisch Gladbach, Germany | ||||
| MetaStat | Corporation | Boston, MA | ||||
| SkylineDX | Venture Capital-Backed | Rotterdam, Netherlands | ||||
| BioLegend | Formerly Accelerator/Incubator backed | San Diego, CA |
Telo Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Telo Genomics Patents
Telo Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-9784666-B2 | Methods for assessing cancer cells using granulometry | Active | 11-Sep-2014 | ||
| US-20160131569-A1 | Methods for assessing cancer cells using granulometry | Active | 11-Sep-2014 | ||
| CA-2895211-A1 | Methods for diagnosing alzheimer's disease | Inactive | 15-Dec-2011 | ||
| CA-2771621-A1 | Methods for diagnosing alzheimer's disease | Inactive | 15-Dec-2011 | ||
| US-20170211145-A1 | Methods for diagnosing alzheimer's disease | Inactive | 15-Dec-2011 | C12Q1/6883 |
Telo Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Telo Genomics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Telo Genomics Acquisitions (1)
Telo Genomics’s most recent deal was a Merger/Acquisition with Plicit Capital. The deal was made on 08-Sep-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Plicit Capital | 08-Sep-2016 | Merger/Acquisition | Real Estate Services (B2C) |
Telo Genomics FAQs
-
When was Telo Genomics founded?
Telo Genomics was founded in 2011.
-
Where is Telo Genomics headquartered?
Telo Genomics is headquartered in Toronto, Canada.
-
What is the size of Telo Genomics?
Telo Genomics has 9 total employees.
-
What industry is Telo Genomics in?
Telo Genomics’s primary industry is Decision/Risk Analysis.
-
Is Telo Genomics a private or public company?
Telo Genomics is a Public company.
-
What is Telo Genomics’s stock symbol?
The ticker symbol for Telo Genomics is TELO.
-
What is the current stock price of Telo Genomics?
As of 16-Apr-2025 the stock price of Telo Genomics is $0.07.
-
What is the current market cap of Telo Genomics?
The current market capitalization of Telo Genomics is $6.81M.
-
Who are Telo Genomics’s competitors?
Miltenyi Biotec, MetaStat, SkylineDX, and BioLegend are competitors of Telo Genomics.
-
What is Telo Genomics’s annual earnings per share (EPS)?
Telo Genomics’s EPS for 12 months was -$0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
